PubRank
Search
About
Levofloxacin Triple and Bismuth Quadruple Therapies for Rescue Treatment of H Pylori Infection
Clinical Trial ID NCT02978157
PubWeight™ 0.00
‹?›
🔗 Visit the ClinicalTrials.gov page for NCT02978157
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Helicobacter pylori infection.
N Engl J Med
2002
14.81
2
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report.
Gut
2012
12.62
3
Helicobacter pylori treatment in the era of increasing antibiotic resistance.
Gut
2010
4.43
4
Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection.
J Gastroenterol Hepatol
2009
3.88
5
Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children.
Am J Gastroenterol
2009
3.18
6
Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition.
Helicobacter
2010
2.50
7
Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection.
Clin Gastroenterol Hepatol
2009
2.15
8
Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis.
Am J Gastroenterol
2006
1.83
9
Endoscopic 13C-urea breath test for the diagnosis of Helicobacter pylori infection.
Dig Liver Dis
2003
1.50
10
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
World J Gastroenterol
2004
1.33
11
Pooled analysis on the efficacy of the second-line treatment regimens for Helicobacter pylori infection.
Scand J Gastroenterol
2001
1.25
12
Correlation of serum immunoglobulin G Helicobacter pylori antibody titers with histologic and endoscopic findings in patients with dyspepsia.
J Clin Gastroenterol
1997
1.06
13
Gastric marginal zone lymphoma of MALT type: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Ann Oncol
2009
0.92
14
Clinical significance of oral urease in diagnosis of Helicobacter pylori infection by [13C]urea breath test.
Dig Dis Sci
2001
0.92
15
Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection.
Scand J Gastroenterol
2013
0.87
16
Efficacy of H. pylori eradication with a sequential regimen followed by rescue therapy in clinical practice.
Dig Liver Dis
2010
0.85
17
Optimal dose of omeprazole for CYP2C19 extensive metabolizers in anti-Helicobacter pylori therapy: pharmacokinetic considerations.
Biol Pharm Bull
2002
0.83
Next 100